RPRX logo

Royalty Pharma plc (RPRX) Free cash flow

annual FCF:

$268.93M-$647.24M(-70.65%)
December 31, 2024

Summary

  • As of today (September 15, 2025), RPRX annual free cash flow is $268.93 million, with the most recent change of -$647.24 million (-70.65%) on December 31, 2024.
  • During the last 3 years, RPRX annual FCF has risen by +$442.37 million (+255.05%).
  • RPRX annual FCF is now -81.86% below its all-time high of $1.48 billion, reached on December 1, 2016.

Performance

RPRX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

quarterly FCF:

$363.98M-$232.09M(-38.94%)
June 30, 2025

Summary

  • As of today (September 15, 2025), RPRX quarterly free cash flow is $363.98 million, with the most recent change of -$232.09 million (-38.94%) on June 30, 2025.
  • Over the past year, RPRX quarterly FCF has dropped by -$294.23 million (-44.70%).
  • RPRX quarterly FCF is now -78.17% below its all-time high of $1.67 billion, reached on December 31, 2019.

Performance

RPRX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

TTM FCF:

$2.41B-$294.23M(-10.90%)
June 30, 2025

Summary

  • As of today (September 15, 2025), RPRX TTM free cash flow is $2.41 billion, with the most recent change of -$294.23 million (-10.90%) on June 30, 2025.
  • Over the past year, RPRX TTM FCF has dropped by -$262.80 million (-9.85%).
  • RPRX TTM FCF is now -23.28% below its all-time high of $3.14 billion, reached on September 30, 2020.

Performance

RPRX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

RPRX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.7%-44.7%-9.8%
3 y3 years+255.1%-36.7%+20.6%
5 y5 years+597.5%-25.6%+29.5%

RPRX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.7%+255.1%-64.8%at low-19.5%+20.6%
5 y5-year-70.7%+255.1%-64.8%at low-23.3%+29.5%
alltimeall time-81.9%+130.8%-78.2%+147.3%-23.3%>+9999.0%

RPRX Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$363.98M(-38.9%)
$2.41B(-10.9%)
Mar 2025
-
$596.08M(-19.7%)
$2.70B(-2.5%)
Dec 2024
$268.93M(-70.6%)
$742.52M(+5.5%)
$2.77B(-1.1%)
Sep 2024
-
$703.61M(+6.9%)
$2.80B(+4.9%)
Jun 2024
-
$658.21M(-1.0%)
$2.67B(+1.9%)
Mar 2024
-
$664.64M(-14.0%)
$2.62B(-12.4%)
Dec 2023
$916.16M(+140.4%)
$772.63M(+34.7%)
$2.99B(+7.3%)
Sep 2023
-
$573.52M(-5.6%)
$2.79B(+1.3%)
Jun 2023
-
$607.82M(-41.2%)
$2.75B(+1.2%)
Mar 2023
-
$1.03B(+81.4%)
$2.72B(+26.8%)
Dec 2022
$381.13M(-319.7%)
$569.93M(+5.8%)
$2.14B(+3.9%)
Sep 2022
-
$538.83M(-6.3%)
$2.06B(+3.5%)
Jun 2022
-
$574.95M(+24.9%)
$1.99B(+2.2%)
Mar 2022
-
$460.27M(-6.1%)
$1.95B(-3.3%)
Dec 2021
-$173.44M
$489.96M(+4.3%)
$2.02B(-3.6%)
DateAnnualQuarterlyTTM
Sep 2021
-
$469.76M(-11.7%)
$2.09B(-1.8%)
Jun 2021
-
$531.72M(+1.1%)
$2.13B(+2.0%)
Mar 2021
-
$526.10M(-7.0%)
$2.09B(+2.7%)
Dec 2020
-$132.53M(+145.2%)
$565.67M(+11.2%)
$2.03B(-35.1%)
Sep 2020
-
$508.85M(+4.1%)
$3.14B(+68.8%)
Jun 2020
-
$489.00M(+3.8%)
$1.86B(+8.9%)
Mar 2020
-
$471.10M(-71.7%)
$1.71B(+2.3%)
Dec 2019
-$54.05M(-104.0%)
$1.67B(-316.6%)
$1.67B(>+9900.0%)
Sep 2019
-
-$769.78M(-328.6%)
$0.00(-100.0%)
Jun 2019
-
$336.79M(-22.2%)
$769.78M(+77.8%)
Mar 2019
-
$432.99M
$432.99M
Dec 2018
$1.35B(-254.6%)
-
-
Dec 2017
-$872.39M(-158.8%)
-
-
Dec 2016
$1.48B(+13.5%)
-
-
Dec 2015
$1.31B
-
-

FAQ

  • What is Royalty Pharma plc annual free cash flow?
  • What is the all time high annual FCF for Royalty Pharma plc?
  • What is Royalty Pharma plc annual FCF year-on-year change?
  • What is Royalty Pharma plc quarterly free cash flow?
  • What is the all time high quarterly FCF for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly FCF year-on-year change?
  • What is Royalty Pharma plc TTM free cash flow?
  • What is the all time high TTM FCF for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM FCF year-on-year change?

What is Royalty Pharma plc annual free cash flow?

The current annual FCF of RPRX is $268.93M

What is the all time high annual FCF for Royalty Pharma plc?

Royalty Pharma plc all-time high annual free cash flow is $1.48B

What is Royalty Pharma plc annual FCF year-on-year change?

Over the past year, RPRX annual free cash flow has changed by -$647.24M (-70.65%)

What is Royalty Pharma plc quarterly free cash flow?

The current quarterly FCF of RPRX is $363.98M

What is the all time high quarterly FCF for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly free cash flow is $1.67B

What is Royalty Pharma plc quarterly FCF year-on-year change?

Over the past year, RPRX quarterly free cash flow has changed by -$294.23M (-44.70%)

What is Royalty Pharma plc TTM free cash flow?

The current TTM FCF of RPRX is $2.41B

What is the all time high TTM FCF for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM free cash flow is $3.14B

What is Royalty Pharma plc TTM FCF year-on-year change?

Over the past year, RPRX TTM free cash flow has changed by -$262.80M (-9.85%)
On this page